Geron Corporation (GERN)
NASDAQ: GERN · Real-Time Price · USD
1.320
-0.050 (-3.65%)
At close: Jun 26, 2026, 4:00 PM EDT
1.319
-0.001 (-0.10%)
After-hours: Jun 26, 2026, 7:57 PM EDT
Geron Employees
Geron had 258 employees as of December 31, 2025. The number of employees increased by 29 or 12.66% compared to the previous year.
Employees
258
Change (1Y)
29
Growth (1Y)
12.66%
Revenue / Employee
$760,136
Profits / Employee
-$260,880
Market Cap
846.81M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| Kura Oncology | 260 |
| Solid Biosciences | 121 |
| Janux Therapeutics | 108 |
| Odyssey Therapeutics | 100 |
| Annexon | 93 |
| Theravance Biopharma | 90 |
| Alto Neuroscience | 68 |
GERN News
- 9 days ago - Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 19 days ago - Geron Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 26 days ago - Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Geron Transcript: AGM 2026 - Transcripts
- 5 weeks ago - Geron Transcript: Stifel 2026 Targeted Oncology Virtual Forum - Transcripts
- 6 weeks ago - Geron Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Geron to present RWE study of RYTELO at EHA Congress - TheFly
- 6 weeks ago - First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026 - GlobeNewsWire